Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Mar 15;10(3):3561-3563.
doi: 10.19102/icrm.2019.100301. eCollection 2019 Mar.

Going Beyond Antiarrhythmic-Anticoagulant Drug Interactions: Considerations in the Complex Medicated Patient

James A Reiffel  1
Affiliations
Comment

Going Beyond Antiarrhythmic-Anticoagulant Drug Interactions: Considerations in the Complex Medicated Patient

James A Reiffel. J Innov Card Rhythm Manag. .
No abstract available

Keywords: Antiarrhythmic; anticoagulation; drug–drug interaction.

PubMed Disclaimer

Conflict of interest statement

Dr. Reiffel has served as an investigator for Boehringer Ingelheim, Medtronic, and Gilead; as a consultant for Janssen, Johnson & Johnson, Portola, Acesion, InCardia Therapeutics; and on the Speakers Bureaus of Janssen and Boehringer Ingelheim within the past three years.

Figures

Figure 1:
Figure 1:
Drug dosing based upon drug pharmacology and drug interaction data. PI: package insert; PK: pharmacokinetic; PD: pharmacodynamic.
See this image and copyright information in PMC

Comment on

References

    1. Konieczny KM, Dorian P. Clinically important drug–drug interactions between antiarrhythmic drugs and anticoagulants. J Innov Cardiac Rhythm Manage. 2019;10(3):3552–3559. doi: 10.19102/icrm.2019.100104. - DOI - PMC - PubMed
    1. Greene R, Dasso E, Ho S, Frank J, Scandrett G, Genaidy A. Patterns and expenditures of multi-morbidity in an insured working population in the United States: insights for a sustainable health care system and building healthier lives. Popul Health Manag. 2013;16(6):381–389. [CrossRef] [PubMed] - DOI - PubMed
    1. Mujica-Mota RE, Roberts M, Abel G, et al. Common patterns of morbidity and multi-morbidity and their impact on health-related quality of life: evidence from a national survey. Qual Life Res. 2015;24(4):909–918. [CrossRef] [PubMed] - DOI - PMC - PubMed
    1. Ruiz M, Bottle A, Long S, Aylin P. Multi-morbidity in hospitalised older patients: who are the complex elderly?. PLoS One. 2015;10(12):e0145372. [CrossRef] [PubMed] - DOI - PMC - PubMed
    1. Schottker B, Saum KU, Muhlack DC, et al. Polypharmacy and mortality: new insights from a large cohort of older adults by detection of effect modification by multimorbidity and comprehensive correction of confounding by indication. Eur J Clin Pharm. 2017;73(8):1041–1048. [CrossRef] [PubMed] - DOI - PubMed

LinkOut - more resources